AmorChem raises C$44.2M toward second fund

Montreal-based VC AmorChem raised C$44.2 million ($34.8 million) toward a planned C$50 million ($39.4 million) life sciences fund.

AmorChem II Fund will invest in seed rounds for biotechs emerging from universities and research centers in Quebec. The fund's LPs include the government of Quebec, Fonds de solidarité FTQ, Merck & Co. Inc. (NYSE:MRK) and undisclosed other investors...